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The most remarkable feature of the immune response is its ability to generate
cells and antibodies specifically reactive with an enormous variety of foreign an-
tigens while normally avoiding the production of autoreactive elements. An ac-
cumulating body ofdata demonstrates that a distinct lineage of B cells (1), the Ly-
1+ B cell subset, does not display this feature, but rather is associated with the
production ofautoreactive antibodies (2). Weare unawareofautoimmunepathology
directly demonstrated to be the result ofan Ly-1 + B cell-Ig product; however, Ly-
1+ B cell frequency is elevated in some autoimmune strains of mice (3). In addi-
tion to theirassociation with autoreactive antibody, Ly-1 + B cells have been shown
to have unique growth potential (1, 4); to produce most of the serum IgM found
in normal, unimmunized animals (4); and the Ig repertoire of the subset may be
restricted (4, 5). These findings imply that this subset has a role in normal physi-
ology, and perhaps autoimmune pathology. A B cell subset has been identified in
humans that bears thehomologous marker Leu-1/T1 (CD5) (6). A similarfunctional
role for CD5+ B cells in man has been proposed (7); human CD5+ B cells have
been shown to produce autoreactive antibody (8, 9) and to be present at elevated
frequency in rheumatoid arthritis (10).
Normal mice produce antibodies that are reactive with protease-treated autolo-
gous erythrocytes (BrMRBC)1 (11); cells producing such antibodies are present in
unimmunized mice at veryhigh frequencies, as first demonstrated by Cunningham
(12). We and others (13-15) have shown that at least some anti-BrMRBC plaque-
formingcells (PFC) recognizethe polarheadgroupofthecommon membrane phos-
pholipid, phosphatidyl choline (PtC). Most splenic anti-BrMRBC PFC have been
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shown to bear the cell surface marker, Ly-1 (2, 16), raising the possibility that anti-
PtC is contained within the putatively restricted repertoire of Ly-1+ B cells.
We demonstrate here that, in the peritoneums ofnormal adult mice, a large number
of lymphocytes bind a fluorescent liposome probe. We show that these cells bind
the liposomes to cell surface IgM by recognizing PtC. Virtually all of these PtC-
specific cells bear the cell surface marker Ly-1. We have found that all the cells that
form plaques on BrMRBC are included in the PtC-specific population and can be
isolated by FRCS. We believe this is the first report of sorting large numbers of B
cells with a single antigen specificity from normal, unimmunized animals. This method
will allow for in vitro and in vivo studies of differentiative and proliferative proper-
ties of Ly-1 + B cells, which may help define their role in development and disease.
Materials and Methods
Mice.
￿
B10.H-2a-H4"p/Wts (2''4") mice were bred and maintained in our pathogen-free
mouse colony. This strain had been developed from selected F2 progeny of B10.A x B10.129
(21M) mice (17). Dr. Charles Sidman (The Jackson Laboratories, Bar Harbor, ME) kindly
provided breeding stock of C3H mice heterozygous for the motheaten viable (me) allele (18).
These mice were also bred in our mouse colony.
Liposomes.
￿
Fluorescent dye-entrapping liposomes were prepared as previously described
(14), except no disulfide-reactive phospholipid was included in the formulation and no anti-
body was coupled to the liposome surface. Liposomes were composed of 45-mole percent
synthetic distearoylphosphatidyl choline, 5-mole percent distearoylphosphatidyl glycerol (Avanti
Polar Lipids, Birmingham, AL), and 50-mole percent cholesterol (Sigma Chemical Co., St.
Louis, MO) and entrapped either 5 mM 6-carboxyfluorescein (CF) or sulforhodamine-B
(SRB) (Eastman Kodak Co., Rochester, NY). Extrusions through microporous membranes
produced liposomes of <0.2 um in diameter.
Preparation of Cell Suspensions.
￿
Mice were killed by cervical dislocation (normal adults) or
C02 asphyxiation (motheaten mice and mice <3 wk old). Peritoneal cells (PerC) were ob-
tained by injecting 5-10 ml RPMI 1640, supplemented with 10% FCS, glutamine, 2-ME,
and gentamicin (B cell medium), into the peritoneal cavity, gently agitating, and withdrawing
medium aseptically with a Pasteur pipette. Cells were washed once and adjusted to 5 x
10`'/ml with the same medium. Samples that contained contaminating erythrocytes were dis-
carded. Spleen, lymph node, and neonatal liver cell suspensions were prepared by teasing
these organs between frosted glass slides. Erythrocytes were removed from spleen and neo-
natal liver samples by treating them with Gey's solution.
Immunofuorescence Analysis.
￿
50 gl of CF liposomes at N2 mM inorganic phophate were
added per 5 x 10" cells. This mixture was incubated for 20 min on ice then washed twice.
For indirect immunofluorescence staining, 5 x 10'' cells were first incubated with saturating
amounts of rat anti-Ly-1 (clone 53-7.3, reference 19), anti-Ly-2 (clone 53-6.7, reference 19),
antiThy-1 (clone H013.4, reference 20), anti-IgM (clone 331 .12, reference 21), or medium
only for 20 min, washed twice, then reacted with mouse anti-rat is fluorescein conjugate (MAR
18.5-FITC; Becton Dickinson & Co., Mountain View, CA) . CF liposomes, SRB liposomes,
or Texas Red-conjugated goat anti-mouse IgM (Fisher Biotech, Orangeburg, NY) were used
as direct immunofluorescence reagents. Flow cytometric analysis and sorting was performed
using an EPICS V cell sorter (Coulter Electronics, Hialeah, FL) with 488 nm excitation from
an argon-ion laser and 568 nm excitation from a krypton-ion laser. We used PBS, which
contained no preservative, as the sheath fluid for all sorting experiments.
Assayfor Anti-BrMRBC PFC.
￿
Sorted peritoneal lymphocytes were washed and resuspended
to 4 x 10' or 3 x 10' cells/ml in RPMI 1640 supplemented with 10% heat-inactivated FCS,
300 wg/ml fresh glutamine, 10' M 2-ME 50 jig/ml LPS W (Difco Laboratories, Inc.,
Detroit, MI), and antibiotics. Cultures were performed by incubating 200 ul of cell suspen-
sion per well of a 96-well tissue culture plate at 37°C in a 5% C02 atmosphere for 2-4 d.
After culture cells were harvested and viable cells were counted in trypan blue. Direct PFCMERCOLINO ET AL.
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were enumerated on a lawn ofBrMRBC using the method of Cunningham and Szenberg
(22) . BrMRBC were prepared as described by Bishop and Haughton (16) .
Results
Normal Mice Contain a Large Number ofLymphocytes Capable ofRecognizing PtC .
￿
We
have suggested that the CH series of B cell lymphomas, 6 of 27 ofwhich produce
IgM that binds PtC (14), represent neoplastic analogs ofnormal Ly-l' B cells (23) .
To test this hypothesis, we looked in normal tissue known to be rich in Ly-l' B cells
(24) with the expectation that a similarly large proportion might be PtC specific.
Fig . 1 shows representative fluorescence histograms from staining 2146 tissue with
PtC-containing fluorescent liposomes . Liposome-binding cells are present at high
frequency in PerC lymphocytes, where Ly-l' B cells predominate . In spleen, the
frequency of liposome-binding cells is shown to be less than one-tenth that ofPerC
lymphocytes, and in lymph nodes they are barely detectable .
By flow cytometry, we measured the frequency of liposome-binding lymphocytes
in PerC from 38 normal, adult 2'46 mice . In Fig . 2 we show how we set our forward-
vs.-log 90° light scatter gates to separate PerC lymphocytes from macrophages . In
comparison with lymph node cells, most PerC lymphocytes are larger and scatter
more light in the forward and log 90° dimensions . The light scatter obtained from
liposome-binding cellscompared with total PerC is also shown . Theliposome-binding
lymphocytes arehomogeneous with respect to light scatter characteristics . They are
shown to be among the largest in PerC, and are larger than all lymph node cells .
Most PerC lymphocytes from 2146 mice have a high surface IgM/IgD ratio (Mer-
colino, TJ., unpublished observation) . Taken together, these observations suggest
that liposome-binding PerC may be totally included in the Ly-l' B cell subset . This
suggestion is consistent with reports that Ly-l' B cells resemble plasmablasts (25),
andhave a characteristically high IgM/IgD ratio (26) . Fig. 3 presents the measured
number ofliposome-binding PerC lymphocytes as a function ofmouse age and sex .
The mean value for bindingobserved in these experiments was >5 0 /0 of the lympho-
cytes . 1-15% liposome-binding PerC lymphocytes were found in each sample . There
was no apparent difference between male and female mice, neither was there any
systematic change in the frequency of liposome-binding lymphocytes between 60
and 450 d of age . Three mice, two females and a male, were notable exceptions ;
in these mice, the measured value for liposome-binding PerC lymphocytes was in-
creased by >2 SD from the population mean . The liposome-binding cells in each
FIGURE 1 .
￿
Tissue distribution ofliposome-binding
cells . The dashed line showsthe fluorescence inten-
sity distribution, on alogarithmic scale, oflympho-
cytes in PerC after staining withCF liposomes . Solid
linesbelow show histograms obtained similarly from
spleniclymphocytesand lymphnode cells. The fre-
quency ofcells within the fluorescence intensity range
indicated is also given for each tissue . These data
come from the tissues ofa single mouse, and are rep-
resentative ofall mice tested . These three histograms
were collected consecutively at thesame fluorescence
sensitivity settings .690
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FIGURE 2 .
￿
Light scatter characteristics of liposome-binding cells . (A) Forward angle light
scatter-vs.-log90' light scatter probability density contours for total PerC . The polygon indi-
cates how we set our light scatter gates to exclude PerC macrophages before collecting fluores-
cence intensity histograms forPerC lymphocytes . Note that within this gate twopopulations exist
with N90% in the population that scatters more light in the forward and log 90' dimensions.
The minorpopulation of smaller cellsfound in PerC overlaps with respect to light scatter charac-
teristics, and hence size, with the lymph node cells (not shown) . To determine the light scatter
properties of liposome-binding cells, we analyzed liposome fluorescence-positive cells. (B) The
liposome-binding cells are totally included in the major, large lymphocyte population in PerC .
of these mice displayed a homogeneous fluorescence profile, an example of which
is shown in Fig . 4 . Using the peak width at half-height as an estimate of variance
in fluorescence intensities measured within each distribution, the sample containing
the increased number of liposome-binding cells has a range of 2.1-fold, compared
with 3.5-fold for the more typical distribution shown . Three other mice had an ob-
vioushomogeneously staining population, yet thetotal number ofliposome-binding
cells was within the normal range . Thus, 6 mice, of a total of 22 that were >6 mo
old, presented the unusual staining pattern . The homogeneous staining pattern may
indicate a narrow range of binding affinity for the liposome probe .
We have studied the ontogeny of cells that bind liposomes, with results shown in
Fig . 5 . Neither 1-d nor 4-d liver or spleen contained a detectable frequency of cells
that bind liposomes (<10 -4) . 8-d-old mice are the youngest mice from which we
could obtain PerC . These mice had levels ofliposome-binding lymphocytesin PerC
of roughly 4 x 10 -4 . By 12 d the number had increased 10-fold, and by -2 wk,
half the adult level was reached . Mice between 3 and 5 wk old contained liposome-
binding cells at the same frequency as normal adults .
To determine the hapten specificity of PerC that bind liposomes, we performed
binding inhibition studies using pure preparations of each of the individual phos-
pholipids used in the probe liposome formulation . As can be seen in Table I, pure
PtC effectively blocked the binding of the fluorescent liposomes to PerC lympho-c
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cytes from 14 of 14 mice. In contrast, phophatidyl glycerol had no effect. We con-
clude that a single hapten specificity (anti-PtC) accounts for the high frequency of
liposome-binding among PerC cells from these normal mice. It is also noteworthy
that the mean fluorescence intensity for the anti-PtC cell population is remarkably
constant between mice, as is the relative inhibition achieved with pure PtC. We take
this to be further evidence indicating similar affinity for PtG in all mice tested.
Virtually All PtC Binders Express I,gM andLy-1.
￿
PerC samples were stained with
anti-IgM and liposomes. When a Texas red conjugate of affinity-purified goat
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FIGURE 3.
￿
Survey of liposome-binding lym-
phocyte frequency in adult 2"46 mice. The
percent liposome-binding cellswithin the lym-
phocyte light scatter gate for individual mice
is plotted as a function of the mouse age in
days. The sex of the mouse is indicated for
males (O) and for females (X). The solid line
shows the mean frequency for all mice, with
the dashed lines at ±1 SD from the mean.
Three mice are shown to be outliers, and as
such have contributed approximately a 2%
increase to the calculated mean, andconsider-
ably broadened the standard deviation. No-
tation with an asterisk indicates the presence
of what appears to be a clone of liposome-
binding cells (see text and Fig. 4).
FIGURE 4.
￿
Clonal expansion in the liposome-
binding cell population. The dashed line shows
a frequency distribution ofliposome-binding cells
from atypical mouse. A representative histogram
from an older mouse with an expanded number
of liposome-binding lymphocytes is drawn as a
solid line. Thefrequency of cells within the indi-
cated fluorescence intensity range is given for each
sample.
FIGURE 5.
￿
Early ontogeny of liposome-
binding lymphocytes. Data represent the
percent liposome-binding cells in the lym-
phocyte population (a determined bylight
scatter) of individual mice plotted as a
function of age. Liver and spleen were
tested from mice <5 d old; all other
samples are PerC. Bracketed data points
are below the limit of detection (<0.01%)
of our method.692 PHOSPHATIDYL CHOLINE-BINDING NORMAL Ly-1' B CELLS
TABLE I
Liposome-binding PerC Lymphocytes Recognize Phosphatidyl Choline
Relative Fluorescence
Exp .
￿
n
￿
Liposome-positive
￿
Control*
￿
PtC blockl
￿
PIG blockS
1
￿
9
￿
6 .47 ± 1 .92 11 ￿1 .00 t 0.15
￿
0.39 ± 0.04
￿
0.98 t 0.13
2
￿
5
￿
8.71 t 1 .67
￿
1 .00 t 0.20
￿
0.41 t 0.04
￿
1 .02 t 0.21
* Relative fluorescence values are expressed as a fraction of the mean fluorescence ( = 1 .00)
for the liposome-binding cell population in untreated samples within an experiment .
l Samples were preincubated with vesicles of pure PIC before addition of an approximately
equimolar amount of PtC/PtG fluorescent liposomes .
4 Samples were similarly preincubated with pure PIG vesicles .
Mean value t
￿
standard error for each measurement .
anti-mouse IgM was used in combination with a fluorescein-containing liposome,
the results shown in Fig . 6A were obtained. 70% ofPerC lymphocytes were shown
to bear surfaceIgM, and alltheliposome-binding cellswere included in this popula-
tion . However, indirect staining with amonoclonal rat anti-mouse Ft (clone 331.12),
followed by mouse anti-rat x (MAR 18.5-FITC), completely blocked liposome
binding, perhaps due to steric interference by the two added antibodies with the
surface IgM molecule . The second-step reagent alone had no effect on liposome
binding, nordid any ofthe other rat antibodies used to phenotype liposome-binding
cells (see below) . Thus, liposome-binding PerC lymphocytes are B cells, and the
blocking result suggests that binding of the probe is by way of surface IgM, as has
been demonstrated for the anti-PtC CH lymphomas (14) . We sought to determine
whether anti-PtC B cells in the peritoneum bear the Ly-1 marker. Using a pool of
FIGURE 6 .
￿
Phenotype ofliposome-binding lymphocytes . A two-color immunofluorescence analysis
of pooled PerC from 5 mice is shown in A . Cells were stained simultaneously withCF liposomes
and Texas red-conjugated goat anti-mouse IgM . Contour plots drawn at absolute levels of cells
with a given staining intensity show that liposome binding cells all bear surface IgM . To generate
the histograms shown in B, we stained pooled PerC from these same five mice with SRB lipo-
somes, then gated on liposome-binding lymphocytes. Samples stained with liposomes and rat
anti-mouse Ly-2/MAR 18.5-FITC resulted in the lower intensity staining profile labeled "Ly-2 .»
Histograms obtained similarly by staining with rat anti-mouse Thy-1.2/MAR 18.5-FITC or with
MAR 18.5-FITC alone (not shown) were indistinguishable from that shown for anti-Ly-2 . Virtu-
ally all cells expressed Ly-1 above this background level, as shown .w
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F[GURE 7.
￿
Motheaten mice have a low frequency
of liposome-binding cells. A fluorescence inten-
sity distribution from a representative individual
C3H.mevlmev mouse (solid line). Virtually all of
the B cells from mevlmev mice are from the Ly-
1' subset (27). The frequency of liposome-
binding cells is seen to be markedly lower than
that for a phenotypically normal C3Hlittermate
(dashedline).
PerC from five mice, we stained with either rat anti-mouse Ly-1, Ly-2, or Thy-1
and PtC-liposomes. The fluorescence intensity distributions for Ly-1 and Ly-2 ex-
pression on liposome binding cells are shown in Fig. 6 B. Histograms obtained for
Thy-1 staining or for the second-step MAR 18.5-FITC alone (not shown) were in-
distinguishable from that shown for Ly-2. Ly-1 expression can be seen to be above
this background for virtuallyall PtC-bindingcells. Thelight scatterfrom liposome-
binding cells shown in Fig. 2 B indicates a homogeneous, large-cell population.
Me Mice Contain Abnormally Low Levels ofAnti-PtC Cells.
￿
Mice that are homozy-
gous for the viable motheaten gene mev suffer from severe autoimmune disease (18).
They have abnormally high numbers of B cells, virtually all ofwhich are of the Ly-1
B cell subset (27). We wanted to know whether the expanded population of Ly-1 +
B cells in young adult C3H mevlme' mice contained large numbers of liposome-
binding cells, or whether the congenital defect interfered with the normal develop-
ment of these cells. Exemplary data shown in Fig. 7 show that the frequency oflipo-
some binding cells in PerC from 10-wk-old C3H mevlmev mice was no higher than
seen in 8-d-old 2a4b mice, whereas PerC from phenotypically normal littermates
were within normal range seen for age-matched 2a4b mice. We conclude that the
expanded population of Ly-1 + B cells in viable motheaten mice does not display the
same antigen specificity distribution as the Ly-1 + B cells of normal, young adult
mice.
Cells that Secrete Antibody Hemolyticfor BrMRBC Are Ly-1 ', PiC Liposome-Binding
Cells. We sought to determine whether the Ly-1 + , PtC liposome-binding cells were
the same as, or were the progenitors of, anti-BrMRBC PFC. From a pool of 2a4b
PerC, we sorted both the lymphocytes that did and those that did not bind CF lipo-
somes. The sorted populations were cultured for 2-4 d in the presence of LPS. In
Table II, data from two representative experiments show that essentially all of the
precursors to cells that, upon LPS stimulation, secrete antibody hemolytic for
BrMRBC are included in thePtC liposome-binding population. The small numbers
ofPFC generated in the sorted, PtC- population can be accounted for by trace con-
tamination with liposome-binding cells. Three other such experiments gave the same
result.
Discussion
In this study, we have demonstrated that fluorochrome-encapsulating liposomes
composed of pure, synthetic phospholipidsare an extremely sensitiveprobe capable694 PHOSPHATIDYL CHOLINE-BINDING NORMAL Ly-1' B CELIS
TABLE II
Anti-BrMRBC PFC Are Ly-1+, PtC Liposome-binding Cells
' To obtain population I, total PerC lymphocytes that had been stained with
PtC liposomes were sorted only on the basis of the forward-vs .-log 90° light
scatter characteristics typical of lymphocytes.
1 Cells that composed population II were obtained by sorting on the basis of
light scatter and the failure to bind PtC liposomes, as determined by log green
fluorescence intensity. Reanalysis ofsorted cells without restaining showed popu-
lation II to be consistently X99% negative for liposome binding.
5 Population III were sorted as the PtC liposome-binding lymphocytes. Reanalysis
of sorted population III cells showed 70-85 % lymphocytes positive for lipo-
some binding.
II Sorted cells were placed in culture with 50 gm/ml LPS for the indicated num-
ber of days before measuring PFC frequency . The initial culture density of
sorted cells for Exp. 1 was 4 x 104/ml, and for Exp. 2, 3 x 105/ml.
Data are means of triplicate determinations from separate cultures.
of identifying very rare cells (0.01%). We have used this technique to detect and
analyze lymphocytes that in normal, unimmunized mice, recognize the common
membrane phopholipid, PtC. We have found that the peritoneums of normal mice
contain many lymphocytes that specifically bind liposomesby recognizingPtC. Using
thebinding of fluorescent liposomes, these cell couldbe identified, enumerated, and
sorted. After cell sorting and stimulation by LPS, we demonstrated that virtually
all peritoneal lymphocytesbearing IgM capable of initiating complement-mediated
lysisof BrMRBC also bind liposomes. This implies that lysis of the RBC was a con-
sequence of recognition of PtC exposed by the proteolytic enzyme. Nearly all of
these cells bear the cell surface marker, Ly-1 .
The findings reported here also have two important technical implications. First
is their bearing upon utilization of fluorescent liposomes for cell staining. We de-
scribed liposomes suitable for use as high signal/noise probes for immunofluores-
cence staining of cells in the process of defining the anti-PtC specificity of anti-
BrMRBC CH lymphomas (14). A similar method has been reported recently (28,
29). The following should be considered in the interpretation of results obtained
using antibody-conjugated liposomes intended to specificity stain lymphocytes: (a)
our present demonstration of a detectable number of PtC-specific cells in both
peritoneum and spleen, (b) the frequent finding of anti-erythrocyte specificity in
human B cell chronic lymphocytic leukemia (B-CLL) (31), and (c) that at least one
of these Leu-1 + (CD5+) B-CLLs recognizes PtC (Mercolino, T. J., unpublished ob-
servation). Second, we believe this to be the initial report of successful sorting of
a significant number ofB cellswith a single antigen-binding specificity from normal,
unimmunized mice. Sorting of PtG liposome-binding PerC may prove useful, for
Exp. Culture
I
Total'
Population
II
PtC- t
III
Ptc'S
d PFC/104 cells
1 311 61 1 3 1,098
3 38 6 961
2 2 179 2 1,725
3 198 2 3,353
4 139 1 3,598MERCOLINO ET AL.
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example, in the study of normal Ly-l' B cell differentiation, as has been previously
described for a transformed clone of Ly-l' B cells (32).
The experimental findings that PtC liposome-binding cells are present at much
higher frequency among PerC than in spleen or lymph node is consistent with a
similar distribution of anti-BrMRBC PFC (27); the absolute level of N7% ofPerC
is in close agreement with the estimate (33) that roughly 1 in 10 PerC B cells are
anti-BrMRBC PFC precursors. The tissue distribution of PtC-bindingcells in the
adult mouse also reflects the tissue distribution of Ly-1' B cells (24). Our results
support the view that the repertoire of Ly-l' B cells may be very restricted since,
at least in PerC, ti10% of these cells have the anti-PtC specificity. Furthermore, the
relative peak position and profile homogeneity of fluorescence intensity for the
liposome-binding population is remarkedly similar between mice, as is the degree
of inhibition by PtC. We interpret this observation as reflecting similar affinity for
hapten in the anti-PtC lymphocyte population. This could be the result of utiliza-
tion of a small number of Ig variable region gene capable of forming the anti-Pte
specificity. The high frequency expression of these gene products in all normal mice
tested must mean that, despite theirapparent autoreactivity, they perform abeneficial
function for the animal. A variety of autoantibody functions have been suggested
including the removal of senescent erythrocytes (12) and damaged tissues (34), an-
tibacterial activity (35), and transport of otherwise insoluble material in the serum
(36). It is also possible that the products of Ly-1' B cells are important as a first-
line, broadly specific defense that recognizes determinants found on commonly en-
countered pathogens. Results reported here, takentogether with the observationthat
the serum IgM present in unimmunized mice is produced by Ly-l' B cells (4), sup-
port this view. As such they may represent nonadaptive Ig, the evolutionary
predecessors to adaptive antibodies whose specificity is generated, in part, by so-
matic mutation.
In this study, we also addressed the ontogeny of anti-PtC lymphocytes using the
direct enumeration of liposome-binding cells. Our observation of the appearance
of PtC-binding cells shows a good correlation with studies of anti-BrMRBC PFC
ontogeny (33, 37). The increase in abundance of PtC-specific, Ly-l' cells during
the first 3 wk of life does not result from an increase in the total Ly-l' B cell popu-
lation. Indeed, the increase in PtC-specific cells occurs during a period in ontogeny
when Ly-l' B cells are decreasing from the overwhelming majority of B cells in neo-
natal mice to a minor subpopulation during the next 2-3 wk (26). Thus, the in-
crease in PtC-specific cells reflects a shift in the expressed repertoire of the Ly-l'
B cell population. In marked contrast, we could find no evidence ofthe normal de-
velopment of PtC-specific cells in viable motheaten (me°/me°) mice. These mice dis-
play an extensive overproduction of Ly-1' B cells for the duration of their short-
ened life (27). Their severe autoimmune disease may result, in part, from continued,
nonspecific proliferation of the Ly-l' B cell compartment that prevents the reper-
toire maturation seen in normal mice.
We have also noted a less predictable change in anti-PtC lymphocyte frequency
late in life: liposome-binding cells are greatly overrepresented in some mice >6 mo
old. Clonal expansion in aging may be a general phenomenon for Ly-l' B cells (38;
38a). Late in life this expansion seems to reach extremes, with small numbers of
clones ofcells greatlyexpanded. Such clonal expression couldbe a step in neoplastic696
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transformation; CD5+ B cells are overrepresented among B cell malignancies in
both humans (7, 39) and mice (23, 40).
The expansion of antigen-specific Ly-l' B cells is presumably controlled. We do
not yet understand what this control might be. The predictable repertoire matura-
tion, together with the evidence of restricted gene usage associated with the PtC
antigen specificity, is consistent with a clonal selection mechanism for the genera-
tion ofthese cells. At present, it is not possible to exclude either an antigen- or idiotype-
driven clonal expansion. An idiotype-specific suppressor effect has been suggested
for at least one of the idiotypes expressed by the PtC-specific Ly-1 + B cells(16), and
selection of the PtC-specific repertoire by antiidiotype has been demonstrated (41).
One feature of Ly-l' B cells that does seem to be different from conventional B
cells is that they can presumably be stimulated to expand in an enviroment that
contains very high levels of antigen. These antigen levels would generallybe consid-
ered tolerogenic forconventional B cells. We have not been able to demonstrate de-
tectable numbers of conventional B cells expressing the PtC specificity. Since we
find no reason to propose that this difference is due to an inability of conventional,
Ly-1 - B cells to express the appropriate Ig genes to encode this specificity, the large
expansion of Ly-l' B cells with this specificity suggests a qualitatively different re-
sponse to antigen between Ly-l' and conventional B cells.
Summary
We have found that, in the peritoneums ofnormal adult mice, 5-15% of lympho-
cytes bind a fluorescent liposome probe. In ontogeny, cells with this specificity were
shown to appear by 8 d after birth, and increase to the adult frequency by 2-3 wk.
Some oldermice contain an expanded population of these cells. We have shownthat
liposome binding occurs by cell surface IgM recognizing the common membrane
phospholipid, phosphatidyl choline (PtC). Virtually all of these PtC-specific cells
bear thecell surface marker Ly-1. Ourresults indicate that roughly 1 in 10 peritoneal
Ly-l' B cells has this single specificity. We have found that the precursors to all the
cellsthat form plaques on protease-treated autologous erythrocytes (BrMRBC) are
included in the PtC-specific population and can be isolated by FAGS. We believe
this is the first report ofsortinglargenumbers of B cellswith a single antigenspecificity
from normal, unimmunizedanimals. This method will allowfor in vitro and in vivo
studies of differentiative and proliferative properties of Ly-l' B cells, which may
help define their role in development and disease.
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cussion and critical review of the manuscript.
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